Explainable machine learning model for predicting the transarterial chemoembolization response and subtypes of hepatocellular carcinoma patients.

Journal: BMC gastroenterology
Published Date:

Abstract

No abstract available for this article.

Authors

  • Yunjie Zhang
    Academy of Clinical Medicine, Guizhou Medical University, Guiyang 550004, China.
  • Songjian Tong
    Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
  • Junhui Yang
    Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
  • Jiawei Lin
    Department of Computer Science, School of Information Science and Technology, Xiamen University, Xiamen 361005, China. 23020161153321@stu.xmu.edu.cn.
  • Yifan Kong
    Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
  • Deyu Lu
    Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325035, People's Republic of China.
  • Yan Chen
    Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Yingchao Li
  • Linfeng Xu
    Department of Mechanical & Aerospace Engineering, University of Florida, Gainesville 32611, FL, USA.
  • Xiuyan Kong
    Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
  • Guoqing Zhu
    School of Urban Construction, Yangtze University, Jingzhou, 434100, China.
  • Hao Zhang
    College of Mechanical and Electrical Engineering, Henan Agricultural University, Zhengzhou, 450002, China.
  • Pixu Liu
    Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
  • Zhijie Yu
    Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325035, People's Republic of China.
  • Jinglin Xia
    Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325035, People's Republic of China.

Keywords

No keywords available for this article.